News & Events
-
November 1, 2016
US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract
November 1, 2016 US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract TUCSON, Ariz., November 1, 2016—The US Food and Drug Administration (FDA) has awarded Critical Path Institute (C-Path) three grants to develop data standards, as well as a contract to continue its research into drug-induced kidney injury. With these awards, the FDA... -
October 31, 2016
Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Huntington’s disease therapeutics
Oct 31, 2016 Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Huntington’s disease therapeutics TUCSON, Ariz., October 31, 2016 — Critical Path Institute (C-Path) and CHDI Foundation, Inc., are collaborating to set up a broad-based consortium that will more clearly define regulatory pathways leading to the approval... -
October 27, 2016
Ensuring Equivalence of Electronic and Paper Administration of Patient-Reported Outcome Measures
This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome (PRO) measures to electronic modes of data collection. Presenters: Paul O’Donohoe, MS (CRF Health) and Willie Muehlhausen, DVM (ICON) -
October 27, 2016
Ensuring Equivalence of Electronic and Paper Administration of Patient-Reported Outcome Measures
This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome (PRO) measures to electronic modes of data collection. Presenters: Paul O’Donohoe, MS (CRF Health) and Willie Muehlhausen, DVM (ICON) PDF version -
October 25, 2016
TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research
Oct 25, 2016 TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research TUCSON, Ariz., October 25, 2016 — The Critical Path Institute’s Critical Path to TB Drug Regimens (CPTR) initiative and the Global TB Programme of the World Health Organization (WHO) have partnered with researchers from the University of California, San Francisco (UCSF),...